Gain-of-function mutations in CARD11 promote enhanced aggregation and idiosyncratic signalosome assembly-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gain-of-function mutations in CARD11 promote enhanced aggregation and idiosyncratic signalosome assembly

Published:2020-07 Issue: Volume:353 Page:104129
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Stinson Jeffrey R.,Dorjbal Batsukh,McDaniel Dennis P.,David Liron,Wu Hao,Snow Andrew L.

Funder

Concern Foundation

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Immunology

Reference49 articles.

1. The CBM-opathies-a rapidly expanding spectrum of human inborn errors of immunity caused by mutations in the CARD11-BCL10-MALT1 complex;Lu;Front. Immunol.,2018

2. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations;Snow;J. Exp. Med.,2012

3. Gain-of-function mutations and immunodeficiency: at a loss for proper tuning of lymphocyte signaling;Arjunaraja;Curr. Opin. Allergy Clin. Immunol.,2015

4. The CARD11-BCL10-MALT1 (CBM) signalosome complex: stepping into the limelight of human primary immunodeficiency;Turvey;J. Allergy Clin. Immunol.,2014

5. Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1;Thome;Cold Spring Harb. Perspect. Biol.,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CARD11 serves as a therapeutic biomarker for the drug therapies of ccRCC;BIOCELL;2024

2. Caspase recruiting domain-containing protein 11 (CARD11) serves as a therapeutic biomarker for the drug therapies of clear cell renal cell carcinoma;2023-12-06

3. Mistuned NF-κB signaling in lymphocytes: lessons from relevant inborn errors of immunity;Clinical and Experimental Immunology;2023-01-18

4. Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience;Frontiers in Immunology;2022-11-03

5. A novel CARD11 germline mutation in a Chinese patient of B cell expansion with NF-κB and T cell anergy (BENTA) and literature review;Frontiers in Immunology;2022-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3